Trial intelligence / Profile preview

KT07 (Lianhua Qingwen) in acute uncomplicated influenza

NCT02867358Phase 2Completed

Sponsor
Yiling Pharmaceutical
Start
Sep 2016
Primary completion
Jul 2020
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

A Phase 2 trial of Lianhua Qingwen in influenza, sponsored by Yiling Pharmaceutical. Started Sep 2016; status: completed.

02

Drugs

Lianhua Qingwen
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02867358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02867358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call